Skip to main content

Showing results for Research Updates

Delaying diabetes: new treatment makes its mark in Indiana

In August 2023, a Riley Hospital for Children patient became the first child in Indiana to receive teplizumab, a groundbreaking therapy that delays the onset of stage 3 type 1 diabetes by an average of three years. The treatment received Federal Drug Administration approval in November 2022, three years after Indiana University School of Medicine researchers conducted clinical trials and published data that helped lead to the FDA’s decision.

Jackie Maupin  |  Sep 25, 2023

Wells Center bestows scientists with awards to fuel pediatric research

The Wells Center for Pediatric Research has recognized several researchers with awards during their spring 2023 round of funding to support five promising projects focused on emerging therapies and clinical and translational pediatric research.

Jackie Maupin  |  Aug 31, 2023

Powerful new genomic sequencing tool available to researchers

IU School of Medicine’s Center for Medical Genomics recently acquired the Illumina NovaSeq X Plus—an instrument that exponentially expands the possibilities of how far next-generation sequencing can go.

IU School of Medicine  |  Aug 29, 2023

July 2023 Research Awards

July 2023 Research Awards

IU School of Medicine  |  Aug 23, 2023

IU researchers uncover mysteries behind immune response to hemophilia A treatment

In a study published in Blood, researchers from Indiana University School of Medicine shed new light on the underlying causes of negative immune responses to factor VIII treatments, providing valuable insights that could lead to more effective and safer hemophilia A treatments in the future. 

Jackie Maupin  |  Aug 10, 2023

June 2023 Research Awards

June 2023 Research Awards

IU School of Medicine  |  Aug 08, 2023

Seven scientists honored with 2023 P&F Awards for advancing diabetes research

Seven scientists from IU School of Medicine have been recognized with 2023 Pilot and Feasibility (P&F) Awards from the Center for Diabetes and Metabolic Diseases (CDMD) at Indiana University School of Medicine, an NIDDK-designated Diabetes Research Center.

Jackie Maupin  |  Aug 03, 2023

IU School of Medicine scientists produce world's 'most impactful' Alzheimer's research

Cristian Lasagna-Reeves, PhD, received an award at the 2023 Alzheimer’s Association International Conference for the “most impactful study published in Alzheimer’s research.” IU School of Medicine is a powerhouse for Alzheimer's research and resources globally.

Laura Gates  |  Jul 19, 2023

Future physicians and scientists take on summer research internships

More than 40 students joined the Wells Center summer internship, MPESC-Prep and IU-CCEH programs as interns at IU School of Medicine this summer.

Jackie Maupin  |  Jul 18, 2023

May 2023 Research Awards

April 2023 Research Awards

IU School of Medicine  |  Jul 12, 2023